These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28324661)

  • 1. Improved Risk Stratification in Pediatric Septic Shock Using Both Protein and mRNA Biomarkers. PERSEVERE-XP.
    Wong HR; Cvijanovich NZ; Anas N; Allen GL; Thomas NJ; Bigham MT; Weiss SL; Fitzgerald JC; Checchia PA; Meyer K; Quasney M; Hall M; Gedeit R; Freishtat RJ; Nowak J; Raj SS; Gertz S; Grunwell JR; Lindsell CJ
    Am J Respir Crit Care Med; 2017 Aug; 196(4):494-501. PubMed ID: 28324661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype.
    Wong HR; Cvijanovich NZ; Anas N; Allen GL; Thomas NJ; Bigham MT; Weiss SL; Fitzgerald J; Checchia PA; Meyer K; Quasney M; Hall M; Gedeit R; Freishtat RJ; Nowak J; Raj SS; Gertz S; Howard K; Harmon K; Lahni P; Frank E; Hart KW; Nguyen TC; Lindsell CJ
    Crit Care Med; 2016 Nov; 44(11):2010-2017. PubMed ID: 27513537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model.
    Wong HR; Weiss SL; Giuliano JS; Wainwright MS; Cvijanovich NZ; Thomas NJ; Allen GL; Anas N; Bigham MT; Hall M; Freishtat RJ; Sen A; Meyer K; Checchia PA; Shanley TP; Nowak J; Quasney M; Chopra A; Fitzgerald JC; Gedeit R; Banschbach S; Beckman E; Lahni P; Hart K; Lindsell CJ
    PLoS One; 2014; 9(1):e86242. PubMed ID: 24489704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology.
    Alder MN; Lindsell CJ; Wong HR
    Expert Rev Anti Infect Ther; 2014 Jul; 12(7):809-16. PubMed ID: 24754535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PERSEVERE Biomarkers Predict Severe Acute Kidney Injury and Renal Recovery in Pediatric Septic Shock.
    Stanski NL; Stenson EK; Cvijanovich NZ; Weiss SL; Fitzgerald JC; Bigham MT; Jain PN; Schwarz A; Lutfi R; Nowak J; Allen GL; Thomas NJ; Grunwell JR; Baines T; Quasney M; Haileselassie B; Wong HR
    Am J Respir Crit Care Med; 2020 Apr; 201(7):848-855. PubMed ID: 31916857
    [No Abstract]   [Full Text] [Related]  

  • 6. Combining Prognostic and Predictive Enrichment Strategies to Identify Children With Septic Shock Responsive to Corticosteroids.
    Wong HR; Atkinson SJ; Cvijanovich NZ; Anas N; Allen GL; Thomas NJ; Bigham MT; Weiss SL; Fitzgerald JC; Checchia PA; Meyer K; Quasney M; Hall M; Gedeit R; Freishtat RJ; Nowak J; Raj SS; Gertz S; Lindsell CJ
    Crit Care Med; 2016 Oct; 44(10):e1000-3. PubMed ID: 27270179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex Cytokine Profiling Identifies Interleukin-27 as a Novel Biomarker For Neonatal Early Onset Sepsis.
    He Y; Du WX; Jiang HY; Ai Q; Feng J; Liu Z; Yu JL
    Shock; 2017 Feb; 47(2):140-147. PubMed ID: 27648693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The temporal version of the pediatric sepsis biomarker risk model.
    Wong HR; Weiss SL; Giuliano JS; Wainwright MS; Cvijanovich NZ; Thomas NJ; Allen GL; Anas N; Bigham MT; Hall M; Freishtat RJ; Sen A; Meyer K; Checchia PA; Shanley TP; Nowak J; Quasney M; Chopra A; Fitzgerald JC; Gedeit R; Banschbach S; Beckman E; Harmon K; Lahni P; Lindsell CJ
    PLoS One; 2014; 9(3):e92121. PubMed ID: 24626215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multibiomarker-Based Model for Estimating the Risk of Septic Acute Kidney Injury.
    Wong HR; Cvijanovich NZ; Anas N; Allen GL; Thomas NJ; Bigham MT; Weiss SL; Fitzgerald J; Checchia PA; Meyer K; Shanley TP; Quasney M; Hall M; Gedeit R; Freishtat RJ; Nowak J; Raj SS; Gertz S; Dawson E; Howard K; Harmon K; Lahni P; Frank E; Hart KW; Lindsell CJ
    Crit Care Med; 2015 Aug; 43(8):1646-53. PubMed ID: 25962083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pediatric sepsis biomarker risk model.
    Wong HR; Salisbury S; Xiao Q; Cvijanovich NZ; Hall M; Allen GL; Thomas NJ; Freishtat RJ; Anas N; Meyer K; Checchia PA; Lin R; Shanley TP; Bigham MT; Sen A; Nowak J; Quasney M; Henricksen JW; Chopra A; Banschbach S; Beckman E; Harmon K; Lahni P; Lindsell CJ
    Crit Care; 2012 Oct; 16(5):R174. PubMed ID: 23025259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association of Corticosteroids and Pediatric Sepsis Biomarker Risk Model (PERSEVERE)-II Biomarker Risk Stratification With Mortality in Pediatric Septic Shock.
    Klowak JA; Bijelić V; Barrowman N; Menon K;
    Pediatr Crit Care Med; 2023 Mar; 24(3):186-193. PubMed ID: 36562614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker Assessment of a High-Risk, Data-Driven Pediatric Sepsis Phenotype Characterized by Persistent Hypoxemia, Encephalopathy, and Shock.
    Atreya MR; Bennett TD; Geva A; Faustino EVS; Rogerson CM; Lutfi R; Cvijanovich NZ; Bigham MT; Nowak J; Schwarz AJ; Baines T; Haileselassie B; Thomas NJ; Luo Y; Sanchez-Pinto LN;
    Pediatr Crit Care Med; 2024 Jun; 25(6):512-517. PubMed ID: 38465952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of a Biomarker-Based Sepsis Mortality Risk Stratification Tool for Pediatric Acute Respiratory Distress Syndrome.
    Yehya N; Wong HR
    Crit Care Med; 2018 Jan; 46(1):e9-e16. PubMed ID: 28991832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker-based risk model to predict persistent multiple organ dysfunctions after congenital heart surgery: a prospective observational cohort study.
    Benscoter AL; Alten JA; Atreya MR; Cooper DS; Byrnes JW; Nelson DP; Ollberding NJ; Wong HR
    Crit Care; 2023 May; 27(1):193. PubMed ID: 37210541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated PERSEVERE and endothelial biomarker risk model predicts death and persistent MODS in pediatric septic shock: a secondary analysis of a prospective observational study.
    Atreya MR; Cvijanovich NZ; Fitzgerald JC; Weiss SL; Bigham MT; Jain PN; Schwarz AJ; Lutfi R; Nowak J; Allen GL; Thomas NJ; Grunwell JR; Baines T; Quasney M; Haileselassie B; Lindsell CJ; Alder MN; Wong HR
    Crit Care; 2022 Jul; 26(1):210. PubMed ID: 35818064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker-Based Risk Stratification in Pediatric Sepsis From a Low-Middle Income Country.
    Ishaque S; Famularo ST; Saleem AF; Siddiqui NUR; Kazi Z; Parkar S; Hotwani A; Thomas NJ; Thompson JM; Lahni P; Varisco B; Yehya N
    Pediatr Crit Care Med; 2023 Jul; 24(7):563-573. PubMed ID: 37092821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Sepsis Biomarker Risk Model Biomarkers and Estimation of Myocardial Dysfunction in Pediatric Septic Shock.
    Lautz AJ; Wong HR; Ryan TD; Statile CJ
    Pediatr Crit Care Med; 2022 Jan; 23(1):e20-e28. PubMed ID: 34560770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shock.
    Calfee CS; Thompson BT; Parsons PE; Ware LB; Matthay MA; Wong HR
    Crit Care Med; 2010 Jun; 38(6):1436-41. PubMed ID: 20386309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock.
    Wong HR; Cvijanovich N; Wheeler DS; Bigham MT; Monaco M; Odoms K; Macias WL; Williams MD
    Am J Respir Crit Care Med; 2008 Aug; 178(3):276-82. PubMed ID: 18511707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department.
    Yin Q; Liu B; Chen Y; Zhao Y; Li C
    Thromb Res; 2013 Oct; 132(4):471-6. PubMed ID: 24035044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.